OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | -78.7% | 12,242 | -63.8% | 0.00% | -100.0% |
| Q1 2023 | $178 | -99.7% | 33,849 | +121.5% | 0.00% | +100.0% |
| Q3 2022 | $63,000 | +53.7% | 15,285 | +51.4% | 0.00% | – |
| Q2 2022 | $41,000 | -68.0% | 10,094 | -45.2% | 0.00% | -100.0% |
| Q4 2021 | $128,000 | -67.3% | 18,415 | -52.9% | 0.00% | -50.0% |
| Q3 2021 | $391,000 | +58.3% | 39,101 | +159.4% | 0.00% | +100.0% |
| Q1 2021 | $247,000 | +10.8% | 15,072 | +39.8% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | -5.5% | 10,778 | -62.0% | 0.00% | -50.0% |
| Q2 2020 | $236,000 | +206.5% | 28,347 | +82.1% | 0.00% | +100.0% |
| Q1 2020 | $77,000 | +140.6% | 15,568 | +47.5% | 0.00% | – |
| Q3 2019 | $32,000 | -93.0% | 10,553 | -78.5% | 0.00% | -100.0% |
| Q1 2017 | $455,000 | +337.5% | 49,024 | +1884.0% | 0.00% | +300.0% |
| Q1 2015 | $104,000 | – | 2,471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
| Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
| DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
| Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
| Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
| Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
| EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
| MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |